Print this page

Result 3 - Prosorba, Rituxan, Splenectomy, Vinca Alkaloids

Selected Treatment Results



PROSORBA* 1.42%   RITUXAN 3.28%   SPLENECTOMY 35.63%   VINCA ALKALOIDS 9.40%
 Platelets      Platelets      Platelets      Platelets  
  › Some 53.85%     › Some 60.00%     › Some 69.63%     › Some 54.65%
  › Sustained 30.77%     › Sustained 13.33%     › Sustained 40.80%     › Sustained 10.47%
 Bleeding      Bleeding      Bleeding      Bleeding  
  › Some 61.54%     › Some 53.33%     › Some 65.44%     › Some 48.28%
  › Normal 23.08%     › Normal 10.00%     › Normal 39.76%     › Normal 16.09%
 Side Effects      Side Effects      Side Effects      Side Effects  
  › Some 53.85%     › Some 53.33%     › Some 43.56%     › Some 75.58%
  › Severe 7.69%     › Severe 3.33%     › Severe 4.91%     › Severe 26.74%
                     


* NOTE: The Prosorba Column is no longer recommended for the treatment of ITP.

Learn More about the Treatments in This Survey